SCHEMBL7299094

SCHEMBL7299094

CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)c1ccc(C)cc1)C(=O)CSCc1ccco1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
POLB P06746 3/20 0.42
MAPT P10636 3/20 0.42
USP2 O75604 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 2/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CTSS P25774 3/20 0.38
CTSK P43235 2/20 0.38
CTSB P07858 4/20 0.38
CTSL P07711 3/20 0.38
CTSC P53634 1/20 0.38
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
CCNA1 P78396 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7299101 1.00 ALDH1A1 (0.44) ALDH1A1NPC1RAB9ASMN1; SMN2POLB
SCHEMBL7303780 0.93 POLB (0.48) ALDH1A1POLBMAPTUSP2HSD17B10
SCHEMBL7303804 0.93 POLB (0.48) ALDH1A1POLBMAPTUSP2HSD17B10
SCHEMBL7313606 0.92 CTSL (0.44) ALDH1A1NPC1RAB9ASMN1; SMN2POLB
SCHEMBL7313599 0.92 CTSL (0.44) ALDH1A1NPC1RAB9ASMN1; SMN2POLB
SCHEMBL7305629 0.92 MAPT (0.44) ALDH1A1SMN1; SMN2POLBMAPTUSP2
SCHEMBL7442938 0.92 MAPT (0.44) ALDH1A1SMN1; SMN2POLBMAPTUSP2
SCHEMBL7308924 0.91 NPC1 (0.49) ALDH1A1NPC1RAB9ASMN1; SMN2POLB
SCHEMBL8887842 0.91 NPC1 (0.49) ALDH1A1NPC1RAB9ASMN1; SMN2POLB
SCHEMBL7301730 0.91 CTSL (0.47) ALDH1A1NPC1RAB9ASMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0525420-B1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors MITSUBISHI CHEM CORP (JP) 1999-05-12 EP disclosed
US-5834508-A PROTEASE ENZYME INHIBITORS; MUSCLE DISORDERS MITSUBISHI CHEMICAL CORPORATION (JP) 1998-11-10 US disclosed
US-5639783-A POTENT PROTEASE INHIBITOR FOR TREATING MUSCULAR, NERVOUS SYSTEM DISEASES MITSUBISHI CHEMICAL CORPORATION (JP) 1997-06-17 US disclosed
EP-0525420-A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors Mitsubishi Chemical Corporation (JP) 1993-02-03 EP disclosed